A Novel UHPLC-MS Method Targeting Urinary Metabolomic Markers for Autism Spectrum Disorder

被引:18
作者
Olesova, Dominika [1 ]
Galba, Jaroslav [2 ]
Piestansky, Juraj [2 ]
Celusakova, Hana [3 ]
Repiska, Gabriela [3 ]
Babinska, Katarina [3 ]
Ostatnikova, Daniela [3 ]
Katina, Stanislav [4 ]
Kovac, Andrej [1 ]
机构
[1] Slovak Acad Sci, Inst Neuroimmunol, Dubravska Cesta 9, Bratislava 84510, Slovakia
[2] Comenius Univ, Fac Pharm, Dept Pharmaceut Anal & Nucl Pharm, Odbojarov 10, Bratislava 83232, Slovakia
[3] Comenius Univ, Fac Med, Inst Physiol, Sasinkova 2, Bratislava 81372, Slovakia
[4] Masaryk Univ, Fac Sci, Inst Math & Stat, Kotlarska 267-2, Brno 61137, Czech Republic
关键词
autism spectrum disorder; liquid chromatography; mass spectrometry; metabolomics; oxidative stress; gut microbiota; OXIDATIVE STRESS; BIOMARKERS;
D O I
10.3390/metabo10110443
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Autism spectrum disorder is a heterogeneous neurodevelopmental disease. Currently, no biomarker of this disease is known. Diagnosis is performed through observation, standardized behavioral scales, and interviews with parents. In practice, diagnosis is often delayed to the average age of four years or even more which adversely affects a child's perspective. A laboratory method allowing to detect the disorder at earlier stages is of a great need, as this could help the patients to start with treatment at a younger age, even prior to the clinical diagnosis. Recent evidence indicates that metabolomic markers should be considered as diagnostic markers, also serving for further differentiation and characterization of different subgroups of the autism spectrum. In this study, we developed an ultra-high performance liquid chromatography-tandem triple quadrupole mass spectrometry method for the simultaneous determination of six metabolites in human urine. These metabolites, namely methylguanidine, N-acetyl arginine, inosine, indole-3-acetic acid, indoxyl sulfate and xanthurenic acid were selected as potential biomarkers according to prior metabolomic studies. The analysis was carried out by means of reversed-phase liquid chromatography with gradient elution. Separation of the metabolites was performed on a Phenomenex Luna(R) Omega Polar C18 (100 x 1.0 mm, 1.6 mu m) column at a flow rate of 0.15 mL/min with acetonitrile/water 0.1% formic acid aqueous as the mobile phase. The analysis was performed on a group of children with autism spectrum disorder and age-matched controls. In school children, we have detected disturbances in the levels of oxidative stress markers connected to arginine and purine metabolism, namely methylguanidine and N-acetylargine. Also, products of gut bacteria metabolism, namely indoxyl sulfate and indole-3-acetic acid, were found to be elevated in the patients' group. We can conclude that this newly developed method is fast, sensitive, reliable, and well suited for the quantification of proposed markers.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 34 条
  • [1] Autism Biomarkers: Challenges, Pitfalls and Possibilities
    Anderson, George M.
    [J]. JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 2015, 45 (04) : 1103 - 1113
  • [2] [Anonymous], 2011, INTRO ROBUST ESTIMAT, DOI DOI 10.1016/C2010-0-67044-1
  • [3] Identification of urinary metabolites that correlate with clinical improvements in children with autism treated with sulforaphane from broccoli
    Bent, Stephen
    Lawton, Brittany
    Warren, Tracy
    Widjaja, Felicia
    Dang, Katherine
    Fahey, Jed W.
    Cornblatt, Brian
    Kinchen, Jason M.
    Delucchi, Kevin
    Hendren, Robert L.
    [J]. MOLECULAR AUTISM, 2018, 9
  • [4] Identification of metabolic pathway disturbances using multimodal metabolomics in autistic disorders in a Middle Eastern population
    Bitar, Tania
    Mavel, Sylvie
    Emond, Patrick
    Nadal-Desbarats, Lydie
    Lefevre, Antoine
    Mattar, Hanna
    Soufia, Michel
    Blasco, Helene
    Vourc'h, Patrick
    Hleihel, Walid
    Andres, Christian R.
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2018, 152 : 57 - 65
  • [5] Oxidative Stress in Autism Spectrum Disorder
    Bjorklund, Geir
    Meguid, Nagwa A.
    El-Bana, Mona A.
    Tinkov, Alexey A.
    Saad, Khaled
    Dadar, Maryam
    Hemimi, Maha
    Skalny, Anatoly V.
    Hosnedlova, Bozena
    Kizek, Rene
    Osredkar, Josko
    Urbina, Mauricio A.
    Fabjan, Teja
    El-Houfey, Amira A.
    Kaluzna-Czaplinska, Joanna
    Gatarek, Paulina
    Chirumbolo, Salvatore
    [J]. MOLECULAR NEUROBIOLOGY, 2020, 57 (05) : 2314 - 2332
  • [6] Chauhan Abha, 2006, Pathophysiology, V13, P171, DOI 10.1016/j.pathophys.2006.05.007
  • [7] Metabolomics Study of Urine in Autism Spectrum Disorders Using a Multiplatform Analytical Methodology
    Dieme, Binta
    Mavel, Sylvie
    Blasco, Helene
    Tripi, Gabriele
    Bonnet-Brilhault, Frederique
    Malvy, Joelle
    Bocca, Cinzia
    Andres, Christian R.
    Nada-Desbarats, Lydie
    Emond, Patrick
    [J]. JOURNAL OF PROTEOME RESEARCH, 2015, 14 (12) : 5273 - 5282
  • [8] GC-MS-based urine metabolic profiling of autism spectrum disorders
    Emond, Patrick
    Mavel, Sylvie
    Aidoud, Nacima
    Nadal-Desbarats, Lydie
    Montigny, Frederic
    Bonnet-Brilhault, Frederique
    Barthelemy, Catherine
    Merten, Marc
    Sarda, Pierre
    Laumonnier, Frederic
    Vourc'h, Patrick
    Blasco, Helene
    Andres, Christian R.
    [J]. ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2013, 405 (15) : 5291 - 5300
  • [9] Eric F., 2020, Swiss ArchivNeurol, Psychiatr Psychotherapy, V171, P3, DOI [10.4414/sanp.2020.03084, DOI 10.4414/SANP.2020.03084]
  • [10] Autistic spectrum disorders: A review of clinical features, theories and diagnosis
    Fakhoury, Marc
    [J]. INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 2015, 43 : 70 - 77